Mobile Heartbeat’s Clinical Communications Platforms MH-CURE and Banyan, Join Epic’s App Orchard Marketplace
The mobile applications integrate with Epic mobile apps Haiku and Rover to provide hospital staff with easy access to secure,...
News
Halberd Receives Patent for Treatment of Cockayne Syndrome – May Provide Pathway to Slow Aging
JACKSON CENTER, PA / ACCESSWIRE / August 25, 2021 / Halberd Corporation (OTC PINK:HALB) received notification from the Ference Law...
Megola Retires Common Stock to Treasury
19,500,000 Common Shares back to Treasury.CEO initiates investigation into past stock issuances that maybe eliminated.LAS VEGAS, NV / ACCESSWIRE /...
Leafbuyer Technologies Announces New Product Line
Company to Capitalize on High Margin, High Demand Segment of Fast-Growing Canna-Tech IndustryDENVER, CO / ACCESSWIRE / August 25, 2021...
Nass Valley Launches CBD Skincare Line and Skincare Value Pack
Vancouver, British Columbia, Aug. 25, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nass Valley Gateway (CSE: NVG.CN) announces the launch of its...
John Wayne Cancer Foundation Charity Trail Run Comes to Flagstaff
John Wayne Grit Series Will Continue in California and TexasCOSTA MESA, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Run in...
Aerami Therapeutics Announces Orphan Drug Designation for Imatinib for the Treatment of Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) affects almost 68,000 patients worldwide, with treatment limited to vasodilators, none of which are disease-modifyingDosing of...
FSD Pharma Announces Definitive Agreement to Acquire Lucid Psycheceuticals
Acquisition Advances Company’s Strategic Plan Toward a Diversified Novel Drug Development Pipeline in Psychedelics and Medical CannabisTORONTO, Aug. 25, 2021...
AIM ImmunoTech Announces Filing of Provisional Patent Application for Use of Ampligen as Both an Intranasal and an IV Therapy for Post-COVID-19 Cognitive Dysfunction (PCCD)
Patients with symptoms of PCCD being treated with Ampligen in the ongoing AMP-511 Early Access Program have reported consistent improvements...
Allied Corp. Initiates Additional Shipment of 200kgs of CBD Distillate From Colombia to Nevada, United States
KELOWNA, British Columbia, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
Olainfarm invites to Second Quarter 2021 Investor Conference Webinar
JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on August...
Orphazyme to host Interim Report First Half 2021 investor call on August 31, 2021
Orphazyme A/SInvestor news No. 08/2021Company Registration No. 32266355 Copenhagen – August 25, 2021 – Orphazyme A/S (ORPHA.CO; ORPH), a late-stage biopharmaceutical...
BBS-Bioactive Bone Substitutes Plc: CORRECTION: Half-Year Report January 1st –June 30th 2021 (Unaudited)
BBS-Bioactive Bone Substitutes Plc’s Company Release August 25th 03.30 p.m. BBS-Bioactive Bone Substitutes Plc corrects its company release published August 25th at 12.45...
BioSyent Releases Q2 and H1 2021 Financial Results
MISSISSAUGA, Ontario, Aug. 25, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for...
Canary Medical to Present Data at the American Academy of Orthopaedic Surgeons (AAOS) 2021 Annual Meeting
VANCOUVER, British Columbia and CARLSBAD, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Canary Medical, a medical data company focused on...
Achilles Therapeutics Announces Grant of US and European Patents
LONDON, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell...
BetterLife Initiates Preclinical Study of AP-003 (rhIFNa2b) against Delta Variant of SARS-CoV-2
VANCOUVER, British Columbia, Aug. 25, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an...
New Study Confirms Sientra’s AlloX2’s Unique Value in Managing Seroma and Infection Post Reconstruction Procedures
SANTA BARBARA, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company...
Connect Biopharma to Host First Half 2021 Financial Results Conference Call on September 1, 2021
SAN DIEGO and TAICANG, SUZHOU, China, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma"...
Arcutis Enrolls First Patient in Phase 3 Clinical Trial of Topical Roflumilast Foam (ARQ-154) as a Potential Treatment for Scalp and Body Psoriasis
Topical roflumilast potential “Best-in-Class” topical PDE4 inhibitorScalp and body psoriasis affects more than 8 million patients in the U.S.WESTLAKE VILLAGE,...